Background: Cervical cancer is the most studied gynaecologic cancer with a clear natural history. Screening for the premalignant lesions has reduced the mortality from cervical …
MH Uijterwaal, NJ Polman, FJ Van Kemenade… - Cancer Prevention …, 2015 - AACR
Primary human papillomavirus (HPV)–based cervical screening will be introduced in the Netherlands in 2016. We assessed the 5-year cervical (pre) cancer risk of women with …
M Rebolj, K Cuschieri, CS Mathews, F Pesola… - bmj, 2022 - bmj.com
Objectives To provide updated evidence about the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) and cervical cancer after a negative human papillomavirus (HPV) …
C Hellsten, A Holmberg, J Astrom… - Acta Obstetricia et …, 2024 - Wiley Online Library
Introduction Primary human papilloma virus (HPV) screening to detect cervical cancer and dysplastic lesions was implemented in Region Skåne 2017 for women aged 30–70. The aim …
MG Dijkstra, M van Zummeren, L Rozendaal… - bmj, 2016 - bmj.com
Objectives To provide an early risk assessment of extending screening intervals beyond five years for a human papillomavirus (HPV) based cervical screening programme in the …
M Schiffman - Preventive medicine, 2017 - ncbi.nlm.nih.gov
Background This special section of Preventive Medicine is devoted to cervical cancer screening. It covers why and how testing for human papillomavirus (HPV) is replacing …
S Salta, JP Sequeira, J Lobo, A Sousa, H Sousa… - Journal of Infection and …, 2024 - Elsevier
Background Cervical cancer screening remains an essential preventive tool worldwide. First line high-risk Human Papillomavirus (HrHPV) genotyping became gold standard for cervical …
Human papillomavirus (HPV) testing is being considered as the primary screening test for cervical cancer in England, rather than the currently used cytology test. We aimed to …